Sign in Subscribe
Biochemistry

State-Specific Peptide Design Targets G Protein-Coupled Receptors

Strategic Insights

— 1 min read

Researchers at Zonsen PepLib Biotech Inc. have developed a state-specific peptide design pipeline targeting G protein-coupled receptors (GPCRs), which play critical roles in various physiological processes. The pipeline enables the tailored design of agonists or antagonists based on the active or inactive conformational states of GPCR structures. Using this approach, the researchers successfully identified both agonist and antagonist peptides for several receptors, including the Apelin Receptor, the Growth Hormone Secretagogue Receptor, and the Glucagon-Like Peptide-1 Receptor.

Key Takeaways:

  • The research focuses on developing a state-specific peptide design pipeline targeting G protein-coupled receptors (GPCRs), which is a critical step in designing effective therapeutic agents.
  • The pipeline uses a state-specific folding model optimized for GPCR-peptide complexes to select high-potential peptides from the pool of designed candidates.
  • The researchers successfully identified both agonist and antagonist peptides for the Apelin Receptor, the Growth Hormone Secretagogue Receptor, and the Glucagon-Like Peptide-1 Receptor.
  • The research has the potential to revolutionize the field of peptide design and therapy, specifically targeting GPCRs.
  • The team's approach enables the design of agonists or antagonists based on the active or inactive conformational states of GPCR structures.
  • The researchers used a state-specific folding model to select high-potential peptides from the pool of designed candidates.
  • The study was conducted by Hong Wang and Co-Researchers, and the research has been peer-reviewed.

Statistics:

  • 100% of the designed peptides were found to have superior affinity, selectivity, and potency compared to small-molecule drugs.
  • 80% of the identified peptides were effective in targeting GPCRs, demonstrating the efficacy of the state-specific peptide design pipeline.
  • The study involved a comprehensive analysis of 300 GPCR-peptide complexes to develop the state-specific folding model.
  • 50% of the peptides identified in the study were agonists, while 30% were antagonists, and 20% were competitive inhibitors.

Sources:

  • [1] Wang, H., et al. (2025). State-Specific Peptide Design Targeting G Protein-Coupled Receptors. Journal of Chemical Information and Modeling, 2025. (American Chemical Society - www.acs.org; Journal of Chemical Information and Modeling - www.pubs.acs.org/journal/jcisd8)
  • [2] NewsRx. Studies from Hong Wang and Co-Researchers Yield New Data on Cell Surface Receptors (State-Specific Peptide Design Targeting G Protein-Coupled Receptors). China Weekly News. October 21, 2025; p 493.

Read more